EnterRx Appoints Geno J. Germano as New Chairman of the Board

EnterRx (NASDAQ: ETRX) announced on February 9, 2026, the appointment of Geno J. Germano, former Executive Vice President of Global Business Development at Pfizer, as Chairman of the Board. Germano brings extensive pharmaceutical industry experience and will focus on steering the company's strategic direction and strengthening its board governance. The move follows the recent leadership transition at the biotechnology firm and is expected to enhance its capital-raising prospects and investor confidence.